FDA Approves Arcutis Biotherapeutics’ Xolive for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis

Xolive is a steroid-free, once-daily treatment that has been proven to provide rapid disease resolution and significant itch relief for patients with mild to moderate atopic dermatitis.